This week saw a round of updates from some of the UK's largest dividend payers, including BP, Shell, Glaxo and British American Tobacco. But is it time for investors to be selling the big names?
The outlook for all the stocks is mixed, with some managers cautious on BP and tobacco giant British American Tobacco (BATs) but others comfortable with what they see as core holdings. BP: The results were undoubtedly positive for the recovering oil major but investors are divided over the outlook from here. Matt Hudson, manager of the top performing £48.8m Cazenove UK Equity Income fund, has been adding to his position in the group, and now favours BP over Shell. "I am taking a more aggressive view now. On a long term view BP is the most attractive investment to have among UK i...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes